Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 1250 of 1467 entries
View as:

24-week Treatment With Lixisenatide in Type 2 Diabetes Insufficiently Controlled With Metformin and Insulin Glargine

Phase: N/A Priority: Normal
NCT ID: NCT00975286 Org: User:
Start: 10/31/09 End: 08/31/11 Due: 08/31/12

Docetaxel and Oxaliplatin in Gastric Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00382720 Org: User:
Start: 09/30/06 End: 04/30/10 Due: 04/30/11

Study of Neoadjuvant Chemotherapeutic Treatment (XELOX) Followed by Chemoradiotherapy (XELOX/RT) and Surgery Versus Chemoradiotherapy Followed by Surgery and Chemotherapy in Patients With High Risk Rectal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00421824 Org: User:
Start: 05/31/06 End: 11/30/10 Due: 11/30/11

Efficacy and Safety of Dianicline Versus Placebo as an Aid to Smoking Cessation

Phase: N/A Priority: Normal
NCT ID: NCT00356967 Org: User:
Start: 06/30/06 End: 06/30/07 Due: 06/30/08

To Evaluate the Safety and Efficacy of Teriflunomide in Patients With Relapsing Forms of Multiple Sclerosis

Phase: N/A Priority: Normal
NCT ID: NCT03856619 Org: User:
Start: 03/27/19 End: 05/13/22 Due: 05/13/23

Long Term Safety of SL77.0499-10 (Alfuzosin) in Patients With BPH

Phase: N/A Priority: Normal
NCT ID: NCT00347061 Org: User:
Start: 05/31/06 End: 10/31/07 Due: 10/31/08

Study to Assess the Efficacy, Safety, and Tolerability of SAR440340/REGN3500/Itepekimab in Chronic Obstructive Pulmonary Disease (COPD)

Phase: N/A Priority: Normal
NCT ID: NCT04701983 Org: User:
Start: 12/16/20 End: 09/01/25 Due: 09/01/26

A Study to Investigate Safety and Efficacy With SAR445514 in Participants With Relapsed/Refractory Multiple Myeloma (RRMM) and Relapsed/Refractory Light-chain Amyloidosis (RRLCA)

Phase: N/A Priority: Normal
NCT ID: NCT05839626 Org: User:
Start: 05/15/23 End: 05/26/25 Due: 05/26/26

Sexuality And Management of Benign Prostatic Hyperplasia With Alfuzosin

Phase: N/A Priority: Normal
NCT ID: NCT00401661 Org: User:
Start: 06/30/06 End: - Due: -

Study to Evaluate Efficacy and Safety of Imiglucerase Treatment in Chinese Patients With Gaucher Disease Type Ⅲ

Phase: N/A Priority: Normal
NCT ID: NCT04656600 Org: User:
Start: 03/02/21 End: 10/12/23 Due: 10/12/24

A Phase 2a/b Study of the Efficacy and Safety of Subcutaneous Amlitelimab in Adults With Nonresponsive Celiac Disease

Phase: N/A Priority: Normal
NCT ID: NCT06557772 Org: User:
Start: 08/29/24 End: 04/10/29 Due: 04/10/30

Rasburicase in Tumor Lysis Syndrome

Phase: N/A Priority: Normal
NCT ID: NCT00302653 Org: User:
Start: 02/28/06 End: - Due: -

Study to Assess the Efficacy, Safety, and Tolerability of SAR440340/REGN3500/Itepekimab in Chronic Obstructive Pulmonary Disease (COPD)

Phase: N/A Priority: Normal
NCT ID: NCT04751487 Org: User:
Start: 02/12/21 End: 09/08/25 Due: 09/08/26

Elitek (Rasburicase) Immuno-Monitoring Study

Phase: N/A Priority: Normal
NCT ID: NCT01097369 Org: User:
Start: 02/28/10 End: 02/28/10 Due: 02/28/11

Irbesartan Effects on Endothelial Dysfunction in Hypertensive Type II Diabetic Patients Comparing Atenolol

Phase: N/A Priority: Normal
NCT ID: NCT00549133 Org: User:
Start: 10/31/03 End: 04/30/05 Due: 04/30/06

SAR3419 in Acute Lymphoblastic Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT01440179 Org: User:
Start: 10/31/11 End: 05/31/14 Due: 05/31/15

An Eight-week Study of SSR411298 as Treatment for Major Depressive Disorder in Elderly Patients

Phase: N/A Priority: Normal
NCT ID: NCT00822744 Org: User:
Start: 12/31/08 End: 02/28/10 Due: 02/28/11

Satavaptan Dose-Ranging Study in Hyponatraemic Patients With Cirrhotic Ascites

Phase: N/A Priority: Normal
NCT ID: NCT00501722 Org: User:
Start: 04/30/04 End: 03/31/05 Due: 03/31/06

A Study to Investigate Long-term Safety and Tolerability of Tolebrutinib in Participants With Multiple Sclerosis.

Phase: N/A Priority: Normal
NCT ID: NCT06372145 Org: User:
Start: 04/16/24 End: 04/30/29 Due: 04/30/30

Efficacy and Safety of the Fixed Dose Combination of Glimepiride+Metformin in Type 2 Diabetic Patients Inadequately Controlled

Phase: N/A Priority: Normal
NCT ID: NCT01699932 Org: User:
Start: 09/30/12 End: 04/30/14 Due: 04/30/15

I SELECT - Irbesartan In Hypertensive Patients With Left Ventricular Hypertrophy

Phase: N/A Priority: Normal
NCT ID: NCT00362037 Org: User:
Start: 03/31/06 End: 06/30/08 Due: 06/30/09

Japanese Efficacy and Safety Study of Enoxaparin in Patients With Curative Abdominal Cancer Surgery

Phase: N/A Priority: Normal
NCT ID: NCT00723216 Org: User:
Start: 03/31/07 End: 12/31/07 Due: 12/31/08

PUMP STUDY MDI Lantus/Lispro vs Continuous Insulin+Lispro

Phase: N/A Priority: Normal
NCT ID: NCT00540709 Org: User:
Start: 11/30/02 End: 09/30/03 Due: 09/30/04

PERSPECTIVE: Telithromycin - Acute Exacerbation of Chronic Bronchitis

Phase: N/A Priority: Normal
NCT ID: NCT00132938 Org: User:
Start: 01/31/04 End: 05/31/06 Due: 05/31/07

Study of the Tolerability, Safety, Pharmacokinetics and Pharmacodynamics of Alirocumab SAR236553 (REGN727)

Phase: N/A Priority: Normal
NCT ID: NCT01448304 Org: User:
Start: 06/30/11 End: 09/30/11 Due: 09/30/12